Pharmaceuticals
Rx-only medicines and US 503A patient-specific compounded preparations. Made under regulatory oversight. Require a prescription.
Wegovy
Novo Nordisk pen; full pharmacopeial QC; covered by Medicare in qualifying patients (2024).
Ozempic
Same molecule as Wegovy; on-label for T2D rather than weight management.
Rybelsus
Oral semaglutide; requires dosing on empty stomach with limited water.
Mounjaro
Lilly KwikPen; on-label for T2D.
Zepbound
Same molecule as Mounjaro; on-label for weight management and OSA.
Saxenda
Daily injection; older than semaglutide.
Victoza
Same molecule as Saxenda; on-label for T2D.
Trulicity
Auto-injector; weekly.
Byetta
BID immediate-release form.
Bydureon BCise
Weekly extended-release form.
Egrifta SV
On-label for HIV lipodystrophy.
Vyleesi
On-demand autoinjector.
Imcivree
Specialty drug; narrow indication.
Scenesse
Subcutaneous implant administered by clinician.
Cerebrolysin
Approved in Europe/Asia; not approved in US.
Increlex
Specialty paediatric Rx.
Zadaxin
Not approved in US; common in EU/Asia.
Pregnyl
Urinary-derived hCG.
Ovidrel
Recombinant hCG.
Geref
Commercially discontinued; reference only.
Pitocin
Hospital-administered only.